It is observed that there were no significant differences in serum CK levels among breast cancer patients with different pathology (P = 0.5687), grade (P = 0.5260), hormone receptor status (P = 0.3557), and molecular subtype (P = 0.1992). This evidence concerns the gene NR4A1 and breast cancer.